landiolol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
beta-adrenoreceptor antagonists 1545 133242-30-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • rapibloc
  • onoact
  • ONO-1101
  • ONO 1101
  • landiolol
  • landiolol hydrochloride
  • landiolol HCl
Landiolol (INN) is a drug which acts as a highly cardioselective, ultra short-acting beta blocker. It is used as an anti-arrhythmic agent.
  • Molecular weight: 509.60
  • Formula: C25H39N3O8
  • CLOGP: 1.83
  • LIPINSKI: 2
  • HAC: 11
  • HDO: 3
  • TPSA: 127.82
  • ALOGS: -3.18
  • ROTB: 14

Drug dosage:

None

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

landiolol